Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial
2020 · The Lancet Neurology · 147 citations
https://doi.org/10.1016/s1474-4422(20)30219-2
P
Per Näsman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
194
Papers
3.5K
Citations
28
h-index
55
i10-index
Per Näsman is an academic researcher from KTH Royal Institute of Technology. The author has contributed to research in topics: Social and Educational Sciences & Cardiovascular Function and Risk Factors & Heart Failure Treatment and Management. The author has an h-index of 28, co-authored 165 publications.
ORCID: 0000-0001-7606-8771Papers by this author
worksDouble-Blind Comparison of Sertraline and Placebo in Stroke Patients With Minor Depression and Less Severe Major Depression
2005 · The Journal of Clinical Psychiatry · 113 citations
https://doi.org/10.4088/jcp.v66n0606
Prognostic Implications of Type 2 Diabetes Mellitus in Ischemic and Nonischemic Heart Failure
2016 · Journal of the American College of Cardiology · 106 citations
https://doi.org/10.1016/j.jacc.2016.06.061
Assessing differences in safety perceptions using GeoAI and survey across neighbourhoods in Stockholm, Sweden
2023 · Landscape and Urban Planning · 84 citations
https://doi.org/10.1016/j.landurbplan.2023.104768
Identifying important barriers to recruitment of patients in randomised clinical studies using a questionnaire for study personnel
2019 · Trials · 37 citations
https://doi.org/10.1186/s13063-019-3737-1
The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: statistical and health economic analysis plan for the trials and for the individual patient data meta-analysis
2017 · Trials · 27 citations
https://doi.org/10.1186/s13063-017-2385-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat